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Magneto-sensitive liposomes can be obtained by encapsulation of magnetic nanoparticles into 
liposomes or by the coverage of magnetic nanoparticles with a lipid bilayer. The so-called 
magnetoliposomes make possible to explore the synergistic effect between chemotherapy and 
magnetic hyperthermia. Recently, both aqueous magnetoliposomes (AMLs, containing magnetic 
nanoparticles entrapped in liposomes) and solid magnetoliposomes (SMLs, where clusters of 
nanoparticles are covered by a lipid bilayer) containing several different nanoparticles (magnetite, 
nickel ferrite, manganese ferrite or magnesium ferrite) have been developed,[1-4] exhibiting a 
superparamagnetic behavior and diameters below 150 nm (figure 1A).  
These nanosystems were successfully tested as carriers for fluorescent potential antitumor drugs.[2-4] 
Fluorescence-based methodologies (FRET, emission quenching and fluorescence anisotropy) have 
been employed as valuable tools for this investigation. Drug-loaded magnetoliposomes have shown 
the ability to interact by fusion with GUVs (giant unilamellar vesicles, used as models of 
biomembranes)[1-3] (figure 1B) and to release the antitumor drugs in in vitro assays using human tumor 
cell lines,[4] being promising for the development of a dual therapy of cancer (combining chemotherapy 
and magnetic hyperthermia). 
  
Figure 1. A: STEM image of solid magnetoliposomes (SMLs) based on Fe3O4 nanoparticles. B: Fluorescence 
spectra of aqueous magnetoliposomes (AMLs) containing both curcumin (as energy donor) and Nile Red (as 
energy acceptor), exciting only curcumin, before and after interaction with GUVs.  
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